NKTR · Nektar Therapeutics
Market Cap
$2.53B
Shares
34.14M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-14 | 2026-06-30 | |
| 8-K | 2026-08-13 | — | |
| 8-K | 2026-06-05 | — | |
| Investor Event Transcript | 2026-06-03 | 2026-06-30 | |
| 8-K | 2026-05-08 | — | |
| 10-Q | 2026-05-08 | 2026-03-31 | |
| 8-K | 2026-05-07 | — | |
| DEF 14A | 2026-04-24 | 2026-06-04 | |
| 8-K | 2026-04-23 | 2026-04-21 | |
| 8-K | 2026-04-20 | — | |
| 8-K | 2026-04-20 | — | |
| 10-K | 2026-03-13 | 2025-12-31 | |
| 8-K | 2026-03-12 | — | |
| 8-K | 2026-02-13 | 2026-02-11 | |
| 8-K | 2026-02-10 | — | |
| 8-K | 2026-02-10 | — | |
| 8-K | 2026-01-27 | — | |
| 8-K | 2025-12-16 | — | |
| 8-K | 2025-11-21 | — | |
| 8-K | 2025-11-10 | 2025-11-08 | |
| 10-Q | 2025-11-07 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-09-18 | — | |
| 10-Q | 2025-08-08 | 2025-06-30 | |
| 8-K | 2025-08-07 | — | |
| 8-K | 2025-07-01 | 2025-06-30 | |
| 8-K | 2025-06-27 | 2025-06-24 | |
| 8-K | 2025-06-24 | — | |
| 8-K | 2025-06-06 | — | |
| 8-K | 2025-06-04 | — | |
| 8-K | 2025-05-28 | 2025-05-23 | |
| 10-Q | 2025-05-09 | 2025-03-31 | |
| 8-K | 2025-05-08 | — | |
| DEF 14A | 2025-04-25 | 2025-05-23 | |
| 8-K | 2025-04-04 | 2025-04-03 | |
| 8-K | 2025-03-28 | — | |
| 10-K | 2025-03-14 | 2024-12-31 | |
| 8-K | 2025-03-12 | — | |
| 8-K | 2025-02-24 | — | |
| 8-K | 2025-02-04 | — | |
| 8-K | 2024-12-02 | — | |
| 10-Q | 2024-11-08 | 2024-09-30 | |
| 8-K | 2024-11-07 | — | |
| 8-K | 2024-11-04 | 2024-11-01 | |
| 10-Q | 2024-08-09 | 2024-06-30 | |
| 8-K | 2024-08-08 | — | |
| 8-K | 2024-06-06 | 2024-06-05 | |
| 10-Q | 2024-05-10 | 2024-03-31 | |
| 8-K | 2024-05-09 | — | |
| DEF 14A | 2024-04-26 | 2024-06-05 |
Showing 1–50 of 129 filings
Key facts
CIK
906709
CUSIP
640268306
13F (30d)
193 filings
193 filers
Visit website
Investor relations